Megan Powell
About Megan Powell
Megan Powell is a Research Associate III at the Broad Institute of MIT and Harvard, specializing in biopharmaceutical downstream process development. She has a background in bioengineering and has previously worked at Ultragenyx Pharmaceutical Inc. and bluebird bio.
Work at Broad Institute
Megan Powell has been employed at the Broad Institute of MIT and Harvard since 2021, serving as a Research Associate III. In this role, she focuses on biopharmaceutical downstream process development. Her work contributes to the advancement of research and development in the biopharmaceutical sector, reflecting her commitment to improving patient outcomes through scientific innovation.
Previous Experience in Biopharmaceuticals
Prior to her current position, Megan Powell gained valuable experience at Ultragenyx Pharmaceutical Inc. She worked there as a Research Associate from 2020 to 2021. Additionally, she held various roles at Ultragenyx, including Downstream PD Co-op in 2018 and Upstream PD Lab Assistant in 2019. Her experience at bluebird bio as a Downstream PD Co-op in 2019 further solidified her expertise in the field.
Education in Bioengineering
Megan Powell earned her Bachelor of Science in Bioengineering from Northeastern University, completing her studies from 2016 to 2020. This educational background provided her with a solid foundation in the principles of bioengineering, which she applies in her professional roles within the biopharmaceutical industry.
Commitment to Patient-Centered Research
Megan Powell demonstrates a strong commitment to patient-centered research and development. This focus is evident in her work at the Broad Institute and her previous roles in the biopharmaceutical sector. Her dedication to enhancing patient outcomes informs her approach to research and process development.